» Articles » PMID: 27861605

Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging

Overview
Journal PLoS One
Date 2016 Nov 19
PMID 27861605
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the diagnostic performance of cerebral blood flow (CBF) by using arterial spin labeling (ASL) perfusion magnetic resonance (MR) imaging to differentiate glioblastoma (GBM) from brain metastasis.

Materials And Methods: The institutional review board of our hospital approved this retrospective study. The study population consisted of 128 consecutive patients who underwent surgical resection and were diagnosed as either GBM (n = 89) or brain metastasis (n = 39). All participants underwent preoperative MR imaging including ASL. For qualitative analysis, the tumors were visually graded into five categories based on ASL-CBF maps by two blinded reviewers. For quantitative analysis, the reviewers drew regions of interest (ROIs) on ASL-CBF maps upon the most hyperperfused portion within the tumor and upon peritumoral T2 hyperintensity area. Signal intensities of intratumoral and peritumoral ROIs for each subject were normalized by dividing the values by those of contralateral normal gray matter (nCBFintratumoral and nCBFperitumoral, respectively). Visual grading scales and quantitative parameters between GBM and brain metastasis were compared. In addition, the area under the receiver-operating characteristic curve was used to evaluate the diagnostic performance of ASL-driven CBF to differentiate GBM from brain metastasis.

Results: For qualitative analysis, GBM group showed significantly higher grade compared to metastasis group (p = 0.001). For quantitative analysis, both nCBFintratumoral and nCBFperitumoral in GBM were significantly higher than those in metastasis (both p < 0.001). The areas under the curve were 0.677, 0.714, and 0.835 for visual grading, nCBFintratumoral, and nCBFperitumoral, respectively (all p < 0.001).

Conclusion: ASL perfusion MR imaging can aid in the differentiation of GBM from brain metastasis.

Citing Articles

Cerebrovascular Reactivity Mapping in Brain Tumors Based on a Breath-Hold Task Using Arterial Spin Labeling.

Calvo-Imirizaldu M, Solis-Barquero S, Aramendia-Vidaurreta V, Garcia de Eulate R, Dominguez P, Vidorreta M NMR Biomed. 2025; 38(3):e5317.

PMID: 39844376 PMC: 11754703. DOI: 10.1002/nbm.5317.


Arterial Spin Labeling: Key Concepts and Progress Towards Use as a Clinical Tool.

Jaafar N, Alsop D Magn Reson Med Sci. 2024; 23(3):352-366.

PMID: 38880616 PMC: 11234948. DOI: 10.2463/mrms.rev.2024-0013.


A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases.

Lange F, Gade R, Einsle A, Porath K, Reichart G, Maletzki C Front Oncol. 2024; 14:1335401.

PMID: 38835368 PMC: 11148222. DOI: 10.3389/fonc.2024.1335401.


Classification of high-grade glioblastoma and single brain metastases using a new SCAT-inception model trained with MRI images.

Lv C, Shu X, Chang H, Qiu J, Peng S, Yu K Front Neurosci. 2024; 18:1349781.

PMID: 38560048 PMC: 10979639. DOI: 10.3389/fnins.2024.1349781.


Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor.

Scola E, Del Vecchio G, Busto G, Bianchi A, Desideri I, Gadda D Cancers (Basel). 2023; 15(11).

PMID: 37296953 PMC: 10252005. DOI: 10.3390/cancers15112992.


References
1.
Strugar J, Rothbart D, Harrington W, Criscuolo G . Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg. 1994; 81(4):560-6. DOI: 10.3171/jns.1994.81.4.0560. View

2.
Ma J, Kim H, Rim N, Kim S, Cho K . Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. AJNR Am J Neuroradiol. 2010; 31(9):1699-706. PMC: 7964975. DOI: 10.3174/ajnr.A2161. View

3.
Yamashita K, Yoshiura T, Hiwatashi A, Togao O, Yoshimoto K, Suzuki S . Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography. Neuroradiology. 2012; 55(2):135-43. DOI: 10.1007/s00234-012-1089-6. View

4.
Server A, Orheim T, Graff B, Josefsen R, Kumar T, Nakstad P . Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and.... Neuroradiology. 2010; 53(5):319-30. DOI: 10.1007/s00234-010-0740-3. View

5.
Yoo R, Choi S, Cho H, Kim T, Lee S, Park C . Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas. J Magn Reson Imaging. 2013; 38(4):852-60. DOI: 10.1002/jmri.24026. View